id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1874586,3af5d910-68a9-47f0-8496-0591913141a9,Q3,ROCK & ASSOCIATES,33545,WOMEN'S INTERNATIONAL PHARMACY,2016,third_quarter,HCR,Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation yet.,"HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2016-10-11T02:59:19.700000-04:00
1874587,3af5d910-68a9-47f0-8496-0591913141a9,Q3,ROCK & ASSOCIATES,33545,WOMEN'S INTERNATIONAL PHARMACY,2016,third_quarter,LAW,"Proposals to amend the Controlled Substances Act to clarify the definition of ""dispense"" to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice.  No specific legislation yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2016-10-11T02:59:19.700000-04:00
1874588,3af5d910-68a9-47f0-8496-0591913141a9,Q3,ROCK & ASSOCIATES,33545,WOMEN'S INTERNATIONAL PHARMACY,2016,third_quarter,BUD,Appropriations (H.R. 5054 and S. 2956) to fund the FDA implementation of compounding pharmacy regulations.,"HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2016-10-11T02:59:19.700000-04:00
1874589,3af5d910-68a9-47f0-8496-0591913141a9,Q3,ROCK & ASSOCIATES,33545,WOMEN'S INTERNATIONAL PHARMACY,2016,third_quarter,PHA,Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.,"HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2016-10-11T02:59:19.700000-04:00